Itamar™ Medical Announces that Publication on the Role of Obstructive Sleep Apnea in Atrial Fibrillation Selected for Inclusion in Circulation’s 2018 Year in Review

Itamar Medical Ltd. (TASE: ITMR), a company that develops, manufactures, and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, today announced that an article previously published in Circulation1 has been selected for inclusion in the journal’s 2018 Year in Review. This review, which appears in the February 2019 issue of Circulation: Arrhythmia and Electrophysiology, comprises the most important and prominent articles of 2018, as determined by the journal’s editors.

CONTACT US
To reach our customer support please send an email to [email protected]
Data Protection
PRIVACY POLICY FOR END USERS
PRIVACY POLICY FOR WEBSITE VISITORS & BUSINESS CONTACTS
Cookie Policy
Terms and Conditions of Sale
Itamar Medical License Agreement
Home Sleep Apnea Test
Itamar Medical - Home Sleep Testing Company Profile
WatchPAT Home Sleep Study Device
Endothelial Dysfunction
Itamar Medical: Medical Device Company & Manufacturer
Diagnosing Sleep Apnea
CONTACT US
© ZOLL Itamar Ltd.
Site by Imaginet
© Itamar Medical Ltd.
Site by Imaginet

When using the marks in our publications and this website, we used the appropriate ™️, ℠, or ®️. The ®️ symbol is used to indicate registrations in the U.S. and the territories listed in https://www.itamar-medical.com/terms-and-conditions/ and this should not mean that such trademarks are necessarily registered in other countries. For example, WatchPAT®️ is a trademark of Itamar Medical Ltd a subsidiary of ZOLL Medical Corporation, in the United States and/or other countries. All other trademarks are the property of their respective owners., registered in the U.S. and the applicable territories listed inhttps://www.itamar-medical.com/terms-and-conditions/ only.

Menu